Attached files

file filename
EX-32 - EX-32 - Celldex Therapeutics, Inc.a2234429zex-32.htm
EX-31.2 - EX-31.2 - Celldex Therapeutics, Inc.a2234429zex-31_2.htm
EX-31.1 - EX-31.1 - Celldex Therapeutics, Inc.a2234429zex-31_1.htm
EX-21.1 - EX-21.1 - Celldex Therapeutics, Inc.a2234429zex-21_1.htm
EX-10.28 - EX-10.28 - Celldex Therapeutics, Inc.a2234429zex-10_28.htm
EX-10.27 - EX-10.27 - Celldex Therapeutics, Inc.a2234429zex-10_27.htm
EX-10.25 - EX-10.25 - Celldex Therapeutics, Inc.a2234429zex-10_25.htm
EX-10.24 - EX-10.24 - Celldex Therapeutics, Inc.a2234429zex-10_24.htm
10-K - 10-K - Celldex Therapeutics, Inc.a2234429z10-k.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

        We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-219867, 333-219869, 333-205694, 333-189336, 333-151728 and 333-117602) and on Form S-3 (Nos. 333-214882 and 333-215747) of Celldex Therapeutics, Inc. of our report dated March 7, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts
March 7, 2018




QuickLinks

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM